tiprankstipranks
Trending News
More News >
Dermapharm Holding (DE:DMP)
:DMP
Germany Market

Dermapharm Holding SE (DMP) Financial Statements

Compare
12 Followers

Dermapharm Holding SE Financial Overview

Dermapharm Holding SE's market cap is currently €2.09B. The company's EPS TTM is €0.62; its P/E ratio is 18.41; and it has a dividend yield of 2.26%. Dermapharm Holding SE is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 1.18B€ 1.14B€ 1.02B€ 942.91M€ 793.83M
Gross Profit€ 767.07M€ 719.16M€ 660.83M€ 620.69M€ 463.48M
Operating Income€ 216.93M€ 182.89M€ 243.69M€ 298.47M€ 136.85M
EBITDA€ 320.91M€ 265.55M€ 329.81M€ 358.10M€ 186.57M
Net Income€ 113.79M€ 62.37M€ 134.24M€ 209.58M€ 85.83M
Balance Sheet
Cash & Short-Term Investments€ 121.71M€ 159.54M€ 161.36M€ 172.06M€ 121.66M
Total Assets€ 2.08B€ 2.16B€ 1.41B€ 1.41B€ 1.22B
Total Debt€ 979.61M€ 1.08B€ 516.45M€ 580.30M€ 606.80M
Net Debt€ 858.42M€ 921.66M€ 366.53M€ 419.98M€ 486.18M
Total Liabilities€ 1.47B€ 1.62B€ 880.34M€ 907.13M€ 899.81M
Stockholders' Equity€ 604.42M€ 539.21M€ 531.59M€ 497.32M€ 321.97M
Cash Flow
Free Cash Flow€ 163.14M€ 177.88M€ 249.52M€ 189.16M€ 90.30M
Operating Cash Flow€ 201.38M€ 219.42M€ 288.53M€ 250.37M€ 131.10M
Investing Cash Flow€ -29.61M€ -415.43M€ -99.01M€ -129.35M€ -105.91M
Financing Cash Flow€ -209.17M€ 204.54M€ -199.77M€ -80.98M€ -14.09M
Currency in EUR

Dermapharm Holding SE Earnings and Revenue History

Dermapharm Holding SE Debt to Assets

Dermapharm Holding SE Cash Flow

Dermapharm Holding SE Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis